Correlation Between PT Bank and Crescita Therapeutics
Can any of the company-specific risk be diversified away by investing in both PT Bank and Crescita Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PT Bank and Crescita Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PT Bank Rakyat and Crescita Therapeutics, you can compare the effects of market volatilities on PT Bank and Crescita Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PT Bank with a short position of Crescita Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PT Bank and Crescita Therapeutics.
Diversification Opportunities for PT Bank and Crescita Therapeutics
-0.76 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between BKRKF and Crescita is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding PT Bank Rakyat and Crescita Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crescita Therapeutics and PT Bank is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PT Bank Rakyat are associated (or correlated) with Crescita Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crescita Therapeutics has no effect on the direction of PT Bank i.e., PT Bank and Crescita Therapeutics go up and down completely randomly.
Pair Corralation between PT Bank and Crescita Therapeutics
Assuming the 90 days horizon PT Bank Rakyat is expected to under-perform the Crescita Therapeutics. But the pink sheet apears to be less risky and, when comparing its historical volatility, PT Bank Rakyat is 22.76 times less risky than Crescita Therapeutics. The pink sheet trades about -0.07 of its potential returns per unit of risk. The Crescita Therapeutics is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 2.10 in Crescita Therapeutics on September 3, 2024 and sell it today you would earn a total of 42.90 from holding Crescita Therapeutics or generate 2042.86% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 98.46% |
Values | Daily Returns |
PT Bank Rakyat vs. Crescita Therapeutics
Performance |
Timeline |
PT Bank Rakyat |
Crescita Therapeutics |
PT Bank and Crescita Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with PT Bank and Crescita Therapeutics
The main advantage of trading using opposite PT Bank and Crescita Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PT Bank position performs unexpectedly, Crescita Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crescita Therapeutics will offset losses from the drop in Crescita Therapeutics' long position.PT Bank vs. Bank Mandiri Persero | PT Bank vs. Piraeus Bank SA | PT Bank vs. Eurobank Ergasias Services | PT Bank vs. Kasikornbank Public Co |
Crescita Therapeutics vs. Pmv Pharmaceuticals | Crescita Therapeutics vs. MediciNova | Crescita Therapeutics vs. Pharvaris BV | Crescita Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |